TY - JOUR AU - Li, Tianhong AU - Ma, Weijie AU - Tian, Eddie C. PY - 2018 TI - Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC JF - Chinese Clinical Oncology; Vol 8, Supplement 1 (October 22, 2019): Chinese Clinical Oncology Y2 - 2018 KW - N2 - Rearrangements of the anaplastic lymphoma kinase ( ALK ) gene were first identified in 2007 and occur in 3 to 5% of all patients with advanced non-small cell lung cancer (NSCLC) (1). UR - https://cco.amegroups.org/article/view/22320